Pfizer Launches "PfizerForAll" to Streamline Healthcare Access for Millions of Americans

PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, C...

August 28, 2024 | Wednesday | News
Label Expansion Makes Omnipod 5 Commercially Available to 6 Million People Living with Insulin-Requiring Type 2 Diabetes

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that its groundbreaki...

August 27, 2024 | Tuesday | News
LIXTE Biotechnology and Netherlands Cancer Institute Dose First Patient in Roche-Supported Trial for Metastatic Colorectal Cancer

LIXTE Biotechnology Holdings, Inc. announced the dosing of the first patient in a new clinical trial in collaboration with the Netherlands Cancer In...

August 27, 2024 | Tuesday | News
Pfizer and BioNTech Launch KP.2-Adapted COVID-19 Vaccine for 2024-2025 Season

The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of...

August 23, 2024 | Friday | News
Curebound Announces Major Milestones for Cancer Research Grants, Secures Over $5.3M in Follow-On Funding

-Curebound, a philanthropic organization that raises and invests strategic funding for cancer research, is announcing important updates on its grant reci...

August 22, 2024 | Thursday | News
FDA Accepts Application for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Acceptance based on Phase 3 CheckMate -9DW trial results demonstrating improved survival with Opdivo (nivolumab) plus Yervoy(ipilimumab) compared to in...

August 22, 2024 | Thursday | News
Roche Strengthens Global Response to Mpox Outbreak with Advanced PCR Testing Solutions

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) te...

August 21, 2024 | Wednesday | News
Emergent BioSolutions Collaborates with WHO and U.S. Government to Combat Mpox Outbreak in Central Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...

August 20, 2024 | Tuesday | News
QIAGEN Singapore Partners with Parkway Group to Enhance Patient Care through Advanced Syndromic Testing

Collaboration to improve patient care and epidemiological monitoring in Parkway Group's  private hospitals  QIAstat-Dx syndromic testing to pr...

August 20, 2024 | Tuesday | News
Fapon Biotech Strengthens Global Response to Monkeypox with Innovative Antigen Diagnostics

  Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...

August 19, 2024 | Monday | News
Lykos Therapeutics Restructures to Focus on Resubmission of NDA for PTSD Treatment Midomafetamine

Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, today announced a reorganization to best support the company as...

August 16, 2024 | Friday | News
Eisai and Biogen Announce Middle East Approval of Alzheimer’s Drug LEQEMBI® (lecanemab) in the UAE

Eisai Co., Ltd. and Biogen Inc. are pleased to announce that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved the hum...

August 15, 2024 | Thursday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close